
Insights from Bayer’s $1.5 Billion VC Fund | Lucio Iannone, Head of Health Venture Investments (VP) at Leaps by Bayer
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
Selecting and Vetting Key Opinion Leaders
Jess asks how KOLs are chosen; Lucio explains CV-based selection, use of AlphaSights and Guidepoint, and practical constraints finding top experts.
Transcript
Play full episode